Mads Liebach Bjerregaard

Member of the company's administrative, management or supervisory body

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Dec 17, 2025 – Mar 5, 2026

Mads Liebach Bjerregaard reported 2 transactions between Dec 17, 2025 and Mar 5, 2026. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
57.4K SEK
2 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
2
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought SynAct Pharma AB shares worth 316,466 SEK between Mar 3, 2026 and Mar 10, 2026

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

4 insiders bought SynAct Pharma AB shares worth 316,466 SEK between Mar 3, 2026 and Mar 10, 2026
Date Insider Transaction Shares Price Value Filing
Mar 3, 2026 Thomas Boesen SACQ Acquisition 2,700 17.90 SEK 48,330 SEK FI filing ↗
Mar 3, 2026 Thomas Boesen SACQ Acquisition 2,750 17.92 SEK 49,280 SEK FI filing ↗
Mar 5, 2026 Jeppe Øvli Øvlesen SACQ Acquisition 7,900 17.99 SEK 142,146 SEK FI filing ↗
Mar 5, 2026 Mads Liebach Bjerregaard SACQ Acquisition 1,500 17.92 SEK 26,880 SEK FI filing ↗
Mar 10, 2026 Anders Kronborg SACQ Acquisition 2,750 18.12 SEK 49,830 SEK FI filing ↗

Total of the rows above: 316,466 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 2 most recent rows are grouped into 2 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. SynAct Pharma AB SACQ Acquisition 1,500 shares 26.9K SEK at 17.92 SEK FI filing ↗
  2. Nordnet Bank AB SACQ Acquisition 1,500 shares 30.5K SEK at 20.35 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
SynAct Pharma AB SE0008241491 SynAct Pharma AB 1,500 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Mads Liebach Bjerregaard reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.